Question-and-Answer Session
Operator
Thank you, sir. (Operator Instructions) Our first question comes from Mark Mahaney from Citigroup. Please go ahead.
Mark Mahaney – Citigroup
Great. Thank you. I wanted to ask a question about some of the impact on your business on customer demand from some of the regulatory changes that have impacted pharmaceutical or health-related advertising, particularly the ISI requirements over the last couple of months. Has that had a material impact in terms of pushing people to advertise more with WebMD? Thank you.
Wayne Gattinella
Yes, Mark. The requirement that advertiser’s pharmaceutical advertisers include the risks within their search advertising and causing them really to pretty much eliminate branded search promotions. We believe it’s helping our business, if I look at our consumer business overall showing healthy growth, we’re seeing major pharma brands beginning to shift dollars from many other venues both offline and online to our properties. We are beginning to really penetrate some of the larger brands at a level that we haven’t seen before.
We think we have a very strong pipeline in several strategic pharma brands that are building for the future. In terms of the new requirement to provide more information regarding patient safety information, we quickly responded to that need by reengineering all of our display advertising in a way that could support this greater disclosure, both in display ads, as well as even in our sponsored video promotion.
So we think overall we’re benefiting certainly from the speed of change to the new requirements and to the extent that it’s eliminated the availability of other channels. We do believe we’re benefiting from that as well.
Operator
Thank you. Our next question comes from James Mitchell from Goldman Sachs. Please go ahead.
James Mitchell - Goldman Sachs
Great, thank you. This is James Mitchell calling on behalf of Jennifer Watson. A couple of questions; one is, could you breakout the contribution to revenue in the quarter from the WebMD Magazine publishing business?
Mark Funston
We don’t separately breakout publishing. As I said, it’s a de minimis part of our revenue. So it’s predominantly the advertising from our magazine, and we’ve just consolidated that because it’s so little into the single line item.
Wayne Gattinella
Yes, I mean, I would just say that the magazine originally was launched as a branding effort. It’s distributed bimonthly to 85% of the doctor’s offices around the country at no charge and it was really meant to really extend the brand at a very important time when people are waiting to see the doctor, and it is supported by advertising. As Mark said, the overall revenue is relatively insignificant, it is a profitable operation and, again we see it as a strong part of our branding overall.
- To read the full transcript on Seeking Alpha, click here »
